Yejinpeng Wang

598 citations
17 papers · 414 indexed · h-index 11
Topics
Ferroptosis and cancer prognosis (9 papers)Bladder and Urothelial Cancer Treatments (8 papers)Epigenetics and DNA Methylation (7 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaOncogene
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yejinpeng Wang

16 papers receiving 410 citations

Peers

Yejinpeng Wang
Comparison fields: 5 of 59
  • Molecular Biology 275
  • Cancer Research 180
  • Pulmonary and Respiratory Medicine 144
  • Surgery 79
  • Oncology 70
Replace Lingming Kong with:
Lingming Kong China
Guangjun Shi China
Zhishi Yang China
Ming-zhe Ma China
Lisi Zheng China
Wenxuan Wu China
Bingjun Lu China
Zhigang Ma China
Sanika Khare United States
Yejinpeng Wang relative to Lingming Kong China Lingming Kong's profile →
Citations per field
00.5×12×
Lingming Kong · 1×
Citations per year

Countries citing papers authored by Yejinpeng Wang

Since Specialization
Citations

This map shows the geographic impact of Yejinpeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yejinpeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yejinpeng Wang more than expected).

Fields of papers citing papers by Yejinpeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yejinpeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yejinpeng Wang. The network helps show where Yejinpeng Wang may publish in the future.

Co-authorship network of co-authors of Yejinpeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yejinpeng Wang. A scholar is included among the top collaborators of Yejinpeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yejinpeng Wang. Yejinpeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 11
3 35
4 10
5 22
6 11
7 15
8 40
9 5
10 5
11 9
12 6
13 45
14 28
15 43
16 91
17 38

About Yejinpeng Wang

Yejinpeng Wang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 17 papers that have together received 414 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (180 citations), Pulmonary and Respiratory Medicine (144 citations) and Molecular Biology (275 citations). Yejinpeng Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yu Xiao, Xinghuan Wang, Kaiyu Qian, Gang Wang, Lingao Ju, Xuefeng Liu, Songtao Cheng, Liang Chen, Liwei Cai and Yi Zhang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026